Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already carry readOnly/idempotent/destructive hints, but the description adds rich behavioral context: fans out across many sources, soft-fails on the USPTO PatentsView sunset, empty sections mean real 'no data' not bugs, FDA products only occur for biologics, and private companies produce resolved:false with a notes line. This far exceeds what annotations alone provide and sets accurate expectations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but structured and dense with value: leading examples, core function, input forms, then a systematic enumeration of returned sections and edge cases. It is front-loaded and every section earns its place, though it could be slightly trimmed without losing meaning.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description fully compensates by enumerating all return keys (cik, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used/sources_failed) and explaining their meanings, plus failure semantics and accepted inputs. An agent has enough to call it correctly and interpret results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description repeats that type accepts 'company' or 'ticker' interchangeably and that value can be ticker, CIK, or name — all already present in the schema. It adds minor examples and the private-company resolution note, but doesn't materially deepen parameter meaning beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user intents ('Tell me about X', 'research Acme') and immediately states the core function: 'full cross-source profile of a US public company in ONE parallel call.' It names the alternatives it stands in for ('chaining single-pack SEC/XBRL/news lookups'), distinguishing itself from piecemeal lookups without needing to reference a sibling by name.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicit guidance is given: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also specifies accepted input forms (ticker, CIK, name) and how private-company failures are presented. It does not explicitly contrast with sibling tools like compare_entities or deep_research, but the holistic-company-profile use case is clearly scoped.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several tool clusters have fuzzy boundaries: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, discover_tools, and suggest_questions all overlap on 'find and query data,' while the five polymarket_* tools plus bet_research form a heavily overlapping prediction-market cluster. The three genuine InterPro tools are clear, but an agent would frequently struggle to pick the right meta-tool.

Naming Consistency3/5

Most tools follow a readable snake_case verb-first pattern like compare_entities, resolve_entity, and validate_claim. However, bare verbs (remember, forget, recall), product-prefixed nouns (pipeworx_feedback, pipeworx_trending), and variant suffixes (ask_pipeworx_beta, ask_pipeworx_grounded) break the pattern enough to feel inconsistent.

Tool Count2/5

34 tools is well above the typical well-scoped range, and many tools duplicate or partially overlap each other's functionality. The count is further inflated by unrelated domains—AI visibility, prediction markets, memory, subscriptions, package auditing—bundled into a server nominally named 'Interpro.'

Completeness2/5

The InterPro subset (search_entries, get_entry, entries_for_protein) is minimal and lacks obvious protein/proteome-level operations, while the rest of the server covers so many unrelated domains that no single domain has clear end-to-end coverage. The Pipeworx query side is broad, but the overall surface feels like several incomplete toolsets merged rather than one complete product.